Illinois ADVANCE

Stay current. Learn on your schedule. 💻

Access web-based CME courses through Illinois ADVANCE featuring timely topics, including:
• GLP-1 RAs for obesity
• Diabetes care
• Buprenorphine
• Ni****ne dependence
• Hyperlipidemia

…and more.

Designed for busy healthcare professionals seeking flexible, evidence-based education anytime, anywhere.

🔗 Explore courses: https://illinoisadvance.uic.edu/education/web-based-cme/

🚭 Helping patients quit to***co is one of the most powerful steps in primary care. Illinois ADVANCE provides up-to-date guidance on pharmacologic treatments and behavioral approaches to support lasting cessation.

Let’s make June a breath of fresh air!
To learn more about the state of to***co in Illinois, check out https://www.lung.org/research/sotc/state-grades/illinois

🚨Public Health Alert:

The DEA is issuing a warning regarding a dangerous new addition to the illicit drug supply: Cychlorphine.

As this synthetic opioid enters Chicago's Illicit drug supply, professionals in healthcare and emergency response need to be aware of three critical factors:

- Extreme Potency: Early reports indicate Cychlorphine is roughly 10x more potent than fentanyl.

- Undetectable: There are currently no commercially available rapid test strips for this substance, like those for fentanyl or xylazine, making it nearly impossible for users or advocates to identify its presence.

- Overdose Response: While naloxone can still work because cychlorphine is an opioid, its high potency means multiple doses may be required to successfully reverse an overdose.

Law enforcement attributes these "designer" opioids to a shift in cartel strategy, constantly altering chemical formulas to bypass regulations.

Please share this with your networks to ensure first responders and harm reduction advocates are prepared for this evolving threat. Source:https://www.cfsre.org/images/content/reports/public_alerts/Public_Alert_N-Propionitrile_Chlorphine_013026.pdf

A new week, a new opportunity to elevate patient outcomes. 📈
We know your clinic hours are packed. That’s why Illinois ADVANCE is designed to be the most convenient "consult" on your calendar.

Designed with busy clinic schedules in mind, these personalized sessions fit seamlessly into your workflow. From science-backed research to practical bedside application, get the insights you need without leaving your office.

Join a growing community of Illinois clinicians committed to excellence.

Schedule your session: https://illinoisadvance.uic.edu/schedule-a-visit/

The medical landscape moves fast -- staying ahead shouldn't feel like a marathon. 🏃‍♂️💨
At Illinois ADVANCE, we help clinicians cut through the noise with concise, evidence-based insights, completely free from pharmaceutical influence.

Our academic detailers bring the latest research and guidelines directly to you, on your schedule, at no cost.

Support better clinical decisions with unbiased data. Book a visit today:
https://illinoisadvance.uic.edu/schedule-a-visit/

Why do clinicians choose Illinois ADVANCE? 🎓
1️⃣ Unbiased, evidence-based data.
2️⃣ Convenient sessions that fit your schedule.
3️⃣ Tailored to your specific patient population.

Best of all? Our services are provided at no cost to you. Let’s elevate Illinois healthcare, one visit at a time. Schedule your in-person or virtual visit here: https://illinoisadvance.uic.edu/education/continuing-medical-education/

Community Spotlight: Women’s Health Awareness Event 🌸

We’re sharing this fantastic upcoming event hosted by our colleagues at UI Health!
"Flourish Together" is a supportive session dedicated to everyday wellness and empowering women with the tools to feel informed and in control of their health. If you are in the Chicago area, we encourage you to check out this resource-filled afternoon.

The Details:
Event: Flourish Together: A Woman's Wellness Event
Date: May 28th, 2026
Time: 11:00 AM – 2:30 PM
Location: UI Health 55th and Pulaski (Health Collaborative) | 5525 South Pulaski Road, Chicago, IL 60629

🔗 Register here (Walk-ins also welcome): https://docs.google.com/forms/d/e/1FAIpQLSek2ZBPQ7bYSb4H9VGLFkhLGfRtZ5POafR46Kt2RpcQrMRhRg/viewform

Today is World Hypertension Day!

As hypertension management continues to evolve with emerging strategies and technologies, staying current with the latest evidence remains essential to improving patient outcomes.

Illinois ADVANCE offers academic detailing to support clinicians in navigating advances in hypertension care through unbiased, evidence-based education.

Together, let’s manage the “silent killer” effectively.

Learn more: https://illinoisadvance.uic.edu/education/academic-detailing-cme/hypertension-cme/

💡 New insight in diabetes care:
In patients with T2DM and ASCVD, the SURPASS-CVOT trial found that tirzepatide was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92).

What does this mean?
CV safety is confirmed, but no additional CV benefit was shown. Tirzepatide demonstrated greater A1C reduction (−1.66% vs −0.88%) and weight loss (−11.6% vs −4.8%), making it a strong option when metabolic goals are a priority.

How are you approaching treatment selection in your practice?
Source: doi:10.1056/NEJMoa2505928

In 2026, "Augmented Intelligence" is changing the pharmacy landscape. 🤖 But with so much tech, how do you keep the "human" in healthcare? Academic detailing offers a personal touch, real experts discussing real data. We help you filter the noise so you can focus on what matters: your patient.